QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan
September 05 2024 - 8:30AM
Business Wire
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company
engaged in research, development, and commercialization of
innovative body imaging systems, is pleased to announce
participation in the International Ultrasonics Symposium (IUS), an
IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society
conference, held in Taipei, Taiwan, on September 22-26, 2024. Dr.
James Wiskin will represent QTI in the Medical Imaging
subsection.
The presentation focusses on a novel application of machine
learning to generate image ‘cleaning’ or removal of artifacts
without compromising diagnostic information, while the quantitative
information is preserved, for accurate diagnoses. This architecture
is applicable to not only breast images, but also the high
resolution, quantitative, reproducible orthopedic and pediatric 3D
images produced by the QTI imaging technology, today and in the
future.
About QT Imaging Holding, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical
device company engaged in research, development, and
commercialization of innovative body imaging systems using low
frequency sound waves. QT Imaging Holdings, Inc. strives to improve
global health outcomes. Its strategy is predicated upon the fact
that medical imaging is critical to the detection, diagnosis, and
treatment of disease and that it should be safe, affordable,
accessible, and centered on the patient’s experience. For more
information on QT Imaging Holdings, Inc., please visit the
company’s website at www.qtimaging.com.
Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging
Holdings, Inc.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements contain words such as “will,” and
“expect,” or the negative thereof or comparable terminology, and
include (without limitation) statements regarding plans for QT
Imaging Holdings, new product development and introduction, and
product sales growth and projected revenues. Forward-looking
statements involve certain risks and uncertainties, and actual
results may differ materially from those discussed in any such
statement. These risks include, but are not limited to: research
results from the use of the Breast Acoustic CT™ Scanner, the
ability of QT Imaging Holdings to sell and deploy the Breast
Acoustic CT™ Scanner, the ability to extend product offerings into
new areas or products, the ability to commercialize technology,
unexpected occurrences that deter the full documentation and “bring
to market” plan for products, trends and fluctuations in the
industry, changes in demand and purchasing volume of customers,
unpredictability of suppliers, the ability to attract and retain
qualified personnel and the ability to move product sales to
production levels. Additional factors that could cause actual
results to differ are discussed under the heading “Risk Factors”
and in other sections of QT Imaging Holding’s (and its predecessor,
GigCapital5, Inc.) filings with the SEC, and in its other current
and periodic reports filed or furnished from time to time with the
SEC. All forward-looking statements in this press release are made
as of the date hereof, based on information available to QT Imaging
Holdings as of the date hereof, and QT Imaging Holdings assumes no
obligation to update any forward-looking statement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240905846805/en/
For media inquiries, please contact: Susan Schaffler Head
of Communications Susan.Schaffler@qtimaging.com
Stas Budagov Chief Financial Officer
Stas.Budagov@qtimaging.com
QT Imaging (NASDAQ:QTI)
Historical Stock Chart
From Sep 2024 to Oct 2024
QT Imaging (NASDAQ:QTI)
Historical Stock Chart
From Oct 2023 to Oct 2024